Controversies in Budd-Chiari Syndrome Management: Potential Role of Liver Stiffness
- PMID: 32287138
- DOI: 10.14309/ajg.0000000000000586
Controversies in Budd-Chiari Syndrome Management: Potential Role of Liver Stiffness
Comment in
-
Response to Mancuso et al.Am J Gastroenterol. 2020 Jun;115(6):953. doi: 10.14309/ajg.0000000000000687. Am J Gastroenterol. 2020. PMID: 32427682 No abstract available.
Comment on
-
ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation.Am J Gastroenterol. 2020 Jan;115(1):18-40. doi: 10.14309/ajg.0000000000000486. Am J Gastroenterol. 2020. PMID: 31895720 Review.
References
-
- Simonetto DA, Singal AK, Garcia-Tsao G, et al. ACG Clinical Guideline: Disorders of the hepatic and mesenteric circulation. Am J Gastroenterol 2020;115:18–40.
-
- Plessier A, Sibert A, Consigny Y, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 2006;44:1308–16.
-
- Seijo S, Plessier A, Hoekstra J, et al. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology 2013;57:1962–8.
-
- Mancuso A. An update on management of Budd-Chiari syndrome: The issues of timing and choice of treatment. Eur J Gastroenterol Hepatol 2015;27:200–3.
-
- He F, Zhao H, Dai S, et al. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome with diffuse occlusion of hepatic veins. Sci Rep 2016;6:36380.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical